ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Johnson and Johnson

Johnson and Johnson (JNJ)

20.38
0.00
( 0.00% )
Updated: 09:33:29
Realtime Data

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
20.38
Bid
20.38
Ask
20.42
Volume
666
20.35 Day's Range 20.41
0.00 52 Week Range 0.00
Previous Close
20.38
Open
20.35
Last Trade
100
@
20.38
Last Trade Time
09:12:48
Average Volume (3m)
-
Financial Volume
-
VWAP
-

JNJ Latest News

Johnson & Johnson to showcase strength of its broad hematology portfolio and pipeline at the 2024 American Society of Hematology Annual Meeting

Johnson & Johnson to showcase strength of its broad hematology portfolio and pipeline at the 2024 American Society of Hematology Annual Meeting PR Newswire RARITAN, N.J., Nov. 19, 2024 More...

Icotrokinra delivered an industry-leading combination of significant skin clearance with demonstrated tolerability in a once daily pill in Phase 3 topline results

Icotrokinra delivered an industry-leading combination of significant skin clearance with demonstrated tolerability in a once daily pill in Phase 3 topline results PR Newswire SPRING HOUSE, Pa...

Nipocalimab demonstrates significant clinical improvement in disease activity and IgG reduction in Phase 2 Sjögren's disease study

Nipocalimab demonstrates significant clinical improvement in disease activity and IgG reduction in Phase 2 Sjögren's disease study PR Newswire WASHINGTON, Nov. 14, 2024 Adults with...

Nipocalimab is the first and only investigational therapy granted U.S. FDA Breakthrough Therapy Designation for the treatment of adults living with moderate-to-severe Sjögren's disease

Nipocalimab is the first and only investigational therapy granted U.S. FDA Breakthrough Therapy Designation for the treatment of adults living with moderate-to-severe Sjögren's disease PR...

Johnson & Johnson submits applications in the U.S. and EU seeking approval of DARZALEX FASPRO® / DARZALEX® as subcutaneous monotherapy for high-risk smoldering multiple myeloma

Johnson & Johnson submits applications in the U.S. and EU seeking approval of DARZALEX FASPRO® / DARZALEX® as subcutaneous monotherapy for high-risk smoldering multiple myeloma PR...

Johnson & Johnson advances leadership in rheumatic disease innovation with 43 abstracts at ACR 2024

Johnson & Johnson advances leadership in rheumatic disease innovation with 43 abstracts at ACR 2024 PR Newswire SPRING HOUSE, Pa., Nov. 7, 2024 New data for investigational nipocalimab in...

Empower 2024 Delivers Groundbreaking Insights and Innovation to Achieve Data-Driven Healthcare

BOWIE, Md., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Inovalon, a leading provider of cloud-based software solutions empowering data-driven healthcare, welcomed industry trailblazers and visionary...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
IFSSInterfield Global Software Inc
$ 0.055
(37.50%)
50k
ZEFIZefiro Methane Corp
$ 0.85
(10.39%)
236.5k
DEERDeere CDR
$ 22.54
(4.45%)
7.84k
JET.BGlobal Crossing Airlines Group Inc
$ 0.69
(2.99%)
6.26k
KNRKontrol Technologies Corp
$ 0.195
(2.63%)
3.4k
CYBNCybin Inc
$ 14.80
(-4.95%)
6.5k
BTQBTQ Technologies Corp
$ 0.30
(-3.23%)
114.5k
SUNNSolarBank Corporation
$ 3.61
(-2.43%)
1,000
GLAS.A.UGlass House Brands Inc
US$ 7.23
(-2.30%)
1.4k
PANWPalo Networks CDR
$ 23.74
(-1.37%)
86.52k
DEFIValour Inc
$ 3.18
(0.95%)
512.31k
ZEFIZefiro Methane Corp
$ 0.85
(10.39%)
236.5k
LITSLithos Energy Ltd
$ 0.055
(0.00%)
141.66k
BTQBTQ Technologies Corp
$ 0.30
(-3.23%)
114.5k
PANWPalo Networks CDR
$ 23.74
(-1.37%)
86.52k

Discussion

View Full Feed
ORCA ORCA 2 minutes ago
SELL DAMMIT SELL.I WANT MY 20 MILLION SHARES BACK.SELL.
VDRM
chemist72 chemist72 2 minutes ago
Sitting by my desk watching our first snowfall of the season wondering if MVNT will ever have another trade. lol
MVNT
diamondguru-one diamondguru-one 2 minutes ago
learn how to read...............
GNCP
pennypop pennypop 2 minutes ago
I think I understand why this is taking so long. Go to Meta AI: type in corporations that Utilize RFE SVM and see what shows up. Then type in corporations within the military industrial complex that utilize RFE SVM and see what you get. This is not some low level algorithm. It’s Keystone. Big matzoh
SVM
pennypop pennypop 2 minutes ago
I think I understand why this is taking so long. Go to Meta AI: type in corporations that Utilize RFE SVM and see what shows up. Then type in corporations within the military industrial complex that utilize RFE SVM and see what you get. This is not some low level algorithm. It’s Keystone. Big matzoh
SVM
BBANBOB BBANBOB 3 minutes ago
TRUE DAT

Like I have stated before, I bought into DNDN at $9.30 watched it tick down for about a month to 6.35 and bailed, three weeks later it was 24$

And I swore I was NOT gonna do that here and have just continued to hold and buy more.........

Hope it
RDGL
Hawkeiz Hawkeiz 3 minutes ago
I agree something big coming 
SINC
Tootall7 Tootall7 3 minutes ago
Yeap they would not understand it.  I would like to vacation sometime in California maybe see Yosemite park and the redwoods
SPY
cableguy cableguy 3 minutes ago
Here we go again just busted over the 50 again, just would like to see it close there, LoL... VHAI
VHAI
ShawnP123 ShawnP123 3 minutes ago
I feel your assessment has been accurate as to the pricing on Nvidia shares. I have had my doubts about the price rolling into the last trading days of December. I don't and won't believe in 150-160. But now I'm even going to move out my first 6 month expectations to the mid second half of 2025. Rea
NVDA
Noghawbuck Noghawbuck 3 minutes ago
Ben’s the best guy for the job I can tell!
FUNN
gp22 gp22 3 minutes ago
$PDYN: AI Software for Robotics partner $RCAT CFO on Fox Business @ 10:40am est.....according to ST poster...Can NOT confirm
PDYN RCAT
tw0122 tw0122 3 minutes ago
.39-.40 up next then .46-.47 if it takes a few weeks chance to load more .30s
RNAZ
delerious1 delerious1 3 minutes ago
Clean Hydrogen Works Awards McDermott FEED Contract for Ascension Clean Energy (ACE) Project
November 21, 2024 07:00 AM Eastern Standard Time
THE WOODLANDS, Texas, & HOUSTON--(BUSINESS WIRE)--Clean Hydrogen Works (CHW) and McDermott announce that CHW has awarded McDermott the front-end
jobynimble jobynimble 3 minutes ago
SPAIF news yesterday…


Sparc AI Inc
Symbol SPAI
Shares Issued 13,044,316
Close 2024-11-20 C$ 0.21
Market Cap C$ 2,739,306
Recent Sedar Documents
View Original Document
Sparc AI talks software licensing


202
SPAI SPAIF
dinogreeves dinogreeves 4 minutes ago
SMCI is backlogged for the next five years. Bring on the audit, so we can move behind this fiasco, bring on Nasdaq extension so people can decide, bring on DOJ dismissal so the market can decide for themselves.
SMCI
snow snow 4 minutes ago
Guong If RD receives a lot of money as early as next week my view is that it is a very good time to invest if you pay 10 cents per share. But there is a real risk that he will not receive the money next week. He himself estimates that there is a 30% risk that he will not receive the money next week
HERB
Investor082 Investor082 4 minutes ago
Doesn’t take away the lies Dr. Zivic spewed. Besides he is not an oncologist. I trust the 70 odd neurologists/neurosurgeons on JAMA paper. However, they don’t go out and utter such non sense. These guys are reasonable and don’t BS like he has been doing over the years!
NWBO
JJZander JJZander 4 minutes ago
CEOS up on Elon tweet 
CEOS
walterc walterc 4 minutes ago
yes

well said and an excellent summary of the market dynamics in the sector.

Exactly how I understand it.
LWLG
getReady getReady 4 minutes ago
JB, we are now passed the five day late filing of the 10-Q. My thought here is we have another acquisition ready....

Failure to Meet the Form 10-Q Filing Deadline
When a company fails to file a 10-Q by the filing deadline, it must make a non-timely (NT) filing of SEC Form NT 10
ASII
Trooperstocks Trooperstocks 4 minutes ago
The Sustainable Green Team (SGTM) is leading the way in creating a greener future! From eco-conscious products to innovative sustainability practices, SGTM is proving that sustainability can drive both positive environmental impact and business success. 🌿

Their current lineup
SGTM
Cribbiobida Cribbiobida 4 minutes ago
So I thought I saw 2561 message from WestTexas indicating this is a dead horse. But why is it now gone?  Checked the Wyoming business site, no more updates on Groen there. 

Regardless, even if we are closing the book on this one, don't regret initial investment. Was an exciting ride,

Your Recent History

Delayed Upgrade Clock